Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Inhomogeneous activity di… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Inhomogeneous activity distribution of (177)Lu-DOTA (0)-Tyr (3)-octreotate and effects on somatostatin receptor expression in human carcinoid GOT1 tumors in nude mice.

Artikel i vetenskaplig tidskrift
Författare Jenny Oddstig
Peter Bernhardt
Helena Lizana
Ola Nilsson
Håkan Ahlman
Lars Kölby
Eva Forssell-Aronsson
Publicerad i Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Volym 33
Nummer/häfte 1
Sidor 229-239
ISSN 1423-0380
Publiceringsår 2012
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för radiofysik
Institutionen för biomedicin, avdelningen för patologi
Institutionen för kliniska vetenskaper, Avdelningen för plastikkirurgi
Institutionen för kliniska vetenskaper
Sidor 229-239
Språk en
Länkar dx.doi.org/10.1007/s13277-011-0268-...
Ämneskategorier Radiofysik

Sammanfattning

The aim of this study was to investigate the activity distribution in neouroendocrine tumors after diagnostic, or therapeutic, amounts of [(177)Lu-DOTA(0)-Tyr(3)]-octreotate and to investigate how the activity distribution influences the absorbed dose. Furthermore, the activity distribution of a second administration of radiolabeled octreotate was studied. Nude mice with subcutaneously grown human midgut carcinoid (GOT1) were injected intravenously with different amounts of (177)Lu-octreotate. At different time points thereafter (4 h to 13 days), a second injection of [(111)In-DOTA(0)-Tyr(3)]-octreotate was given to estimate the somatostatin receptor (sstr) expression. The activity distribution in the tumors was then determined. Monte Carlo simulations with PENELOPE were performed for dosimetry. Fifty-one out of 58 investigated tumors showed a lower activity concentration in the peripheral part than in the central part of the tumor. The amount of activity injected, or time after administration, did neither influence the relative activity nor the sstr distribution in the tumor. After an initial down-regulation (at 4-24 h), there was an up-regulation of sstr (1.5-2 times, at 7-14 days). Monte Carlo simulations demonstrated an inhomogeneous absorbed dose distribution in the tumor using (177)Lu, with twice as high absorbed dose centrally than peripherally. The high activity concentration centrally and the up-regulation of sstr demonstrated will facilitate fractionated therapy using radiolabeled somatostatin analogues if similar results will be obtained also in patients. The inhomogeneous activity distribution in the tumor has to be taken into account when the absorbed dose distribution in tumor is calculated.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?